Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Roche
Company Monitoring Page for Roche
latest headlines for company on cafepharma
Investigational immunotherapy anti-PDL1 (MPDL3280A) shrank tumours in 43 percent of people with a specific type of metastatic bladder cancer in a Roche study
Pipeline Review
Sun, 06/1/14 - 11:48 am
Tags:
MPDL3280A
,
Roche
,
bladder cancer
Italy to seek $1.6 billion damages from Roche, Novartis
Marketwatch
Thu, 05/29/14 - 01:14 pm
Tags:
Italy
,
Roche
,
Novartis
,
antitrust
,
Lucentis
Immune Therapy’s Cancer Promise Creates Research Rush
Bloomberg
Thu, 05/29/14 - 08:52 am
Tags:
cancer immunotherapy
,
Merck
,
MK-3475
,
Roche
,
Yervoy
,
Bristol-Myers Squibb
,
Merck KGaA
,
AstraZeneca
3 Breakthrough Drugs Yield 1 Instant Blockbuster
Motley Fool
Sun, 05/25/14 - 10:26 am
Tags:
Roche
,
Gazyva
,
Imbruvica
,
JNJ
,
Gilead Sciences
,
Sovaldi
,
mantle cell lymphoma
,
chronic lymphocytic leukemia
,
leukemia
,
Biogen
,
hepatitis
,
hepatitus C
Roche Says Authorities Visited Office in China’s Hangzhou
Bloomberg
Thu, 05/22/14 - 08:42 am
Tags:
China
,
Roche
Roche Immune Therapy Drug Helps Bladder Cancer Patients
Bloomberg
Thu, 05/15/14 - 11:00 am
Tags:
Roche
,
bladder cancer
,
MPDL3280A
Bristol, Merck, Roche immune therapies are cancer meeting focus
Yahoo/Reuters
Thu, 05/15/14 - 08:24 am
Tags:
Bristol-Myers Squibb
,
Merck
,
Roche
,
ASCO
,
cancer
,
anti-PD-1 immunotherapy
Cancer drugs from J&J, Roche, Celgene and more rival last big oncology wave
Fierce Pharma Marketing
Thu, 05/8/14 - 12:30 pm
Tags:
oncology
,
JNJ
,
Roche
,
Celgene
,
Zytiga
,
Kadcyla
,
Nexavar
,
Gleevec
Why Merck Is Still A Big Pharma Kingpin
Seeking Alpha
Mon, 05/5/14 - 08:26 am
Tags:
Merck
,
Bristol-Myers Squibb
,
Gilead Sciences
,
Roche
,
MK-3475
,
hepatitis C
New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala
Seeking Alpha
Wed, 04/30/14 - 12:50 pm
Tags:
melanoma
,
Bristol-Myers Squibb
,
Roche
,
Merck
,
Amgen
Drug innovation: In the recovery room
FT.com
Fri, 04/25/14 - 03:21 pm
Tags:
innovation
,
Roche
,
Novartis
,
GSK
,
Merck
,
Bristol-Myers Squibb
FDA approves Roche HPV DNA test for primary cervical cancer screening
Yahoo/Fly on the Wall
Thu, 04/24/14 - 05:56 pm
Tags:
FDA
,
Roche
,
DNA
,
cervical cancer
,
HPV
,
cobas HPV test
NICE rejects Roche's hot new breast cancer drug Kadcyla, then invites negotiations
Fierce Pharma
Wed, 04/23/14 - 12:02 pm
Tags:
breast cancer
,
Roche
,
NICE
,
Kadcyla
,
HER2-positive metastatic breast cancer
Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff
Seeking Alpha
Mon, 04/21/14 - 04:46 pm
Tags:
Taxotere
,
Rexahn
,
RX-21101
,
patents
,
patent cliff
,
Bristol-Myers Squibb
,
Roche
,
Sanofi
The Biggest Biotech Wins of the Week
Motley Fool
Thu, 04/17/14 - 07:46 am
Tags:
biotech
,
Puma Biotechnology
,
aripiprazole lauroxil
,
Alkermes
,
neratinib
,
Roche
,
Herceptin
,
bemaciclib
,
breast cancer
,
Eli Lilly
Roche adds a slate of PhIII schizophrenia trial failures to bitopertin's obituary
Fierce Biotech
Wed, 04/16/14 - 09:10 am
Tags:
bitopertin
,
Roche
,
schizophrenia
Adverse currency moves hit Roche first-quarter sales
Yahoo/Reuters
Tue, 04/15/14 - 09:30 am
Tags:
Roche
,
earnings
Novartis to Shire Said to Weigh Bids for ThromboGenics
Bloomberg
Mon, 04/14/14 - 06:49 pm
Tags:
Shire
,
ThromboGenics
,
Novartis
,
Roche
,
Valeant Pharmaceuticals
,
Regeneron
,
Allerg
Roche's Competitive Advantage
Seeking Alpha
Fri, 04/11/14 - 08:43 am
Tags:
Roche
,
JNJ
,
Merck
,
Pfizer
Roche says did not collude with Novartis to restrict competition
Reuters
Thu, 04/10/14 - 10:46 am
Tags:
Roche
,
Novartis
,
collusion
Pages
« first
‹ previous
…
70
71
72
73
74
75
76
77
78
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.